Natalie Staplin
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
Papers in
- Nephrology 29
- Chronic Kidney Disease and Diabetes 22
- Dialysis and Renal Disease Management 7
-
- Diabetes Treatment and Management 19
- Co-authors
- Colin Baigent (31 shared papers)William G. Herrington (38 shared papers)Richard Haynes (35 shared papers)Jonathan Emberson (25 shared papers)Martin Landray (25 shared papers)Parminder K. Judge (11 shared papers)Bryan Williams (7 shared papers)Luis Miguel Ruilope (7 shared papers)
- Journals
- Nephrology Dialysis Transplantation (8 papers)Clinical Journal of the American Society of Nephrology (7 papers)Kidney International (6 papers)Journal of the American Society of Nephrology (5 papers)Hypertension (5 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Natalie Staplin
90 papers receiving 11.4k citations
Natalie Staplin's Hit Papers
Peers
Comparison fields: 5 of 160
- Infectious Diseases 4.6k
- Nephrology 1.0k
- Neurology 2.0k
- Critical Care and Intensive Care Medicine 470
- Endocrinology, Diabetes and Metabolism 1.4k
Countries citing papers authored by Natalie Staplin
This map shows the geographic impact of Natalie Staplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Staplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Staplin more than expected).
Fields of papers citing papers by Natalie Staplin
This network shows the impact of papers produced by Natalie Staplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Staplin. The network helps show where Natalie Staplin may publish in the future.
Co-authors
The 25 scholars most cited alongside Natalie Staplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dexamethasone in Hospitalized Patients with Covid-19. Hit paper breakdown → | 2020 | 6645 |
| 2 | Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials Hit paper breakdown → | 2022 | 747 |
| 3 | 2020 | 519 | |
| 4 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 501 |
| 5 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 6 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes Hit paper breakdown → | 2023 | 200 |
| 7 | Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients Hit paper breakdown → | 2023 | 192 |
| 8 | 2018 | 192 | |
| 9 | 2018 | 188 | |
| 10 | Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials Hit paper breakdown → | 2024 | 101 |
| 11 | Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis Hit paper breakdown → | 2024 | 100 |
| 12 | 2015 | 93 | |
| 13 | Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report | 2020 | 88 |
| 14 | 2022 | 87 | |
| 15 | 2016 | 84 | |
| 16 | 2023 | 77 | |
| 17 | 2016 | 71 | |
| 18 | 2020 | 68 | |
| 19 | 2023 | 65 | |
| 20 | 2014 | 64 |
About Natalie Staplin
Natalie Staplin is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 96 papers that have together received 11.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (22 papers), Diabetes Treatment and Management (19 papers), Blood Pressure and Hypertension Studies (10 papers), Dialysis and Renal Disease Management (7 papers), COVID-19 Clinical Research Studies (5 papers), Potassium and Related Disorders (5 papers), Genetic Associations and Epidemiology (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Infectious Diseases (4.6k citations), Nephrology (1.0k citations), Neurology (2.0k citations), Critical Care and Intensive Care Medicine (470 citations) and Endocrinology, Diabetes and Metabolism (1.4k citations). Natalie Staplin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Colin Baigent, William G. Herrington, Richard Haynes, Jonathan Emberson, Martin Landray, Parminder K. Judge, Bryan Williams, Luis Miguel Ruilope, Alejandro de la Sierra and Ernest Vinyoles. Their work appears in journals such as Nephrology Dialysis Transplantation, Clinical Journal of the American Society of Nephrology, Kidney International, Journal of the American Society of Nephrology and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.